You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

DESOXIMETASONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Desoximetasone, and what generic alternatives are available?

Desoximetasone is a drug marketed by Actavis Mid Atlantic, Cosette, Fougera Pharms, Lupin, Padagis Israel, Rising, Sciegen Pharms Inc, Zydus Lifesciences, Epic Pharma Llc, Padagis Us, Altana, Glenmark Pharms Ltd, Novel Labs Inc, Pai Holdings Pharm, and The J Molner. and is included in thirty NDAs.

The generic ingredient in DESOXIMETASONE is desoximetasone. There are seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the desoximetasone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Desoximetasone

A generic version of DESOXIMETASONE was approved as desoximetasone by PADAGIS ISRAEL on July 1st, 2003.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DESOXIMETASONE?
  • What are the global sales for DESOXIMETASONE?
  • What is Average Wholesale Price for DESOXIMETASONE?
Drug patent expirations by year for DESOXIMETASONE
Drug Prices for DESOXIMETASONE

See drug prices for DESOXIMETASONE

Drug Sales Revenue Trends for DESOXIMETASONE

See drug sales revenues for DESOXIMETASONE

Recent Clinical Trials for DESOXIMETASONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Wake Forest University Health SciencesPhase 4
Psoriasis Treatment Center of Central New JerseyPhase 4
SPS MEDICAL CO.,LTD.Phase 3

See all DESOXIMETASONE clinical trials

Pharmacology for DESOXIMETASONE
Medical Subject Heading (MeSH) Categories for DESOXIMETASONE
Paragraph IV (Patent) Challenges for DESOXIMETASONE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
TOPICORT Topical Spray desoximetasone 0.25% 204141 1 2013-12-18

US Patents and Regulatory Information for DESOXIMETASONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Lifesciences DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 205206-001 Sep 19, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lupin DESOXIMETASONE desoximetasone SPRAY;TOPICAL 208124-001 Mar 16, 2018 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Actavis Mid Atlantic DESOXIMETASONE desoximetasone CREAM;TOPICAL 205082-001 Sep 4, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Epic Pharma Llc DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 201005-001 Apr 24, 2014 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.